Clearline Capital LP Vincerx Pharma, Inc. Transaction History

Clearline Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.64 - $1.32 $226,091 - $466,313	-353,268 Reduced 78.12%	98,916 $100,000
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.0 $0 - $0	39,527 Added 9.58%	452,184 $597,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	281,801 Added 215.35%	412,657 $1.65 Million
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	130,856 New	130,856 $1.33 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Clearline Capital LP, based on Form 13F filings with the SEC.

Stay updated on Clearline Capital LP with notifications on news.